7.155USD-3.83%Mkt Cap: 7.56B USDP/E: —Last update: 2026-06-01
ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against c…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap7.56B USD
Enterprise Value8.62B USD
Revenue (TTM)140.98M USD
Gross Profit112.53M USD
Net Income (TTM)-351.40M USD
Revenue/Share0.1460 USD
Last Price7.155 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees684
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45256X1037
Valuation
P/E (Trailing)—
P/E (Forward)125.33
PEG—
EV/EBITDA-35.13
EV/Revenue61.15
P/S55.87
P/B-9.05
EPS (TTM)-0.85
EPS (Forward)0.06
52W Range
1.95050% of range12.43
52W High12.43 USD
52W Low1.950 USD
Profitability
Gross Margin99.34%
Oper. Margin-157.88%
EBITDA Margin-174.08%
Profit Margin-310.18%
ROE70.21%
ROA-70.01%
Growth
Revenue Growth167.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-304.94M USD
CapEx (TTM)4.25M USD
FCF Margin-137.40%
FCF Yield-2.56%
Net Debt743.73M USD
Net Debt/EBITDA-3.03
Balance Sheet
Debt/Equity-1.04
Current Ratio6.67
Quick Ratio6.24
Book Value/Sh-0.8310 USD
Cash/Share0.3640 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)13.00 USD
Target Range12.00 USD – 15.00 USD
# Analysts3
Ownership
Shares Out.1.05B
Float394.04M
Insiders62.48%
Institutions17.57%
Short Interest
Short Ratio10.4d
Short % Float34.18%
Short % Out.12.68%
Shares Short132.75M
Short (prev mo.)140.33M
Technical
SMA 507.709 (-7.2%)
SMA 2004.779 (+49.7%)
Beta0.07
S&P 52W Chg27.94%
Avg Vol (30d)13.37M
Avg Vol (10d)16.23M
Technical Indicators
RSI (14)45.7
MACD-0.0108
MACD Signal0.0385
MACD Hist.-0.0493
BB Upper8.573 USD
BB Middle7.846 USD
BB Lower7.118 USD
BB Width18.54%
ATR (14)0.6178 USD
Vol Ratio (20d)0.75x